Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Health Care Winner
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.
(
) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 0.6%. By the end of trading, Regeneron Pharmaceuticals rose $4.47 (1.7%) to $273.67 on light volume. Throughout the day, 430,782 shares of Regeneron Pharmaceuticals exchanged hands as compared to its average daily volume of 1,196,600 shares. The stock ranged in a price between $268.71-$276.51 after having opened the day at $270.41 as compared to the previous trading day's close of $269.20. Other companies within the Health Care sector that increased today were:
(
), up 228.7%,
(
), up 44.2%,
(
), up 32.7% and
(
), up 29.0%.
Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally. Regeneron Pharmaceuticals has a market cap of $25.8 billion and is part of the drugs industry. Shares are up 57.4% year to date as of the close of trading on Monday. Currently there are 10 analysts that rate Regeneron Pharmaceuticals a buy, no analysts rate it a sell, and 5 rate it a hold.
TheStreet Ratings rates
Regeneron Pharmaceuticals
as a
. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and compelling growth in net income. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.
- You can view the full Regeneron Pharmaceuticals Ratings Report.
On the negative front,
(
), down 37.8%,
(
), down 16.3%,
(
), down 12.5% and
(
), down 10.9% , were all laggards within the health care sector with
(
) being today's health care sector laggard.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider
Health Care Select Sector SPDR
(
) while those bearish on the health care sector could consider
ProShares Ultra Short Health Care
(
).
- Find other investment ideas from our top rated ETFs lists.
null